234 related articles for article (PubMed ID: 16014269)
1. [Treatment of uncontrollable, life-threatening hemorrhage].
Stensballe J; Lethagen S; Johansson PI
Ugeskr Laeger; 2005 Jun; 167(25-31):2789-90. PubMed ID: 16014269
[TBL] [Abstract][Full Text] [Related]
2. [Rational treatment of uncontrollable, life-threatening hemorrhage with recombinant factor VIIa].
Stensballe J; Lethagen S; Lippert F; Johansson PI;
Ugeskr Laeger; 2005 Jun; 167(25-31):2756-9. PubMed ID: 16014259
[TBL] [Abstract][Full Text] [Related]
3. [Rational blood component therapy in patients with life-threatening hemorrhage].
Johansson PI; Lethagen S; Lippert FK; Stensballe J;
Ugeskr Laeger; 2005 Jun; 167(25-31):2753-5. PubMed ID: 16014258
[TBL] [Abstract][Full Text] [Related]
4. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
[TBL] [Abstract][Full Text] [Related]
5. [Indications of blood components and outcome of transfusion practices in hemorrhage of multiple trauma].
Audibert G
Cah Anesthesiol; 1994; 42(3):391-4. PubMed ID: 7812868
[TBL] [Abstract][Full Text] [Related]
6. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
7. Coagulation management in massive bleeding.
Griffee MJ; Deloughery TG; Thorborg PA
Curr Opin Anaesthesiol; 2010 Apr; 23(2):263-8. PubMed ID: 20104172
[TBL] [Abstract][Full Text] [Related]
8. [Uncontrollable bleeding in a patient with head trauma treated with blood component therapy guided by thromboelastography].
Hansen MK; Jensen MK; Andersen C
Ugeskr Laeger; 2006 Oct; 168(41):3535-6. PubMed ID: 17059810
[TBL] [Abstract][Full Text] [Related]
9. [Fibrinogen substitution. Use in the treatment of bleeding due to lack of fibrinogen].
Ingerslev J; Sørensen B
Ugeskr Laeger; 2005 Jun; 167(25-31):2759-61. PubMed ID: 16014260
[TBL] [Abstract][Full Text] [Related]
10. [Recombinant activated Factor VII (Novo Seven) for uncontrollable hemorrhage in critically ill patients with multiple injuries].
Pernazza F; Olearis A
Minerva Chir; 2004 Apr; 59(2):XVII-XIX. PubMed ID: 15455479
[No Abstract] [Full Text] [Related]
11. Exsanguination in trauma: A review of diagnostics and treatment options.
Geeraedts LM; Kaasjager HA; van Vugt AB; Frölke JP
Injury; 2009 Jan; 40(1):11-20. PubMed ID: 19135193
[TBL] [Abstract][Full Text] [Related]
12. Red-blood-cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: a retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie.
Maegele M; Lefering R; Paffrath T; Tjardes T; Simanski C; Bouillon B;
Vox Sang; 2008 Aug; 95(2):112-9. PubMed ID: 18557827
[TBL] [Abstract][Full Text] [Related]
13. The impact of uncross-matched blood transfusion on the need for massive transfusion and mortality: analysis of 5,166 uncross-matched units.
Inaba K; Teixeira PG; Shulman I; Nelson J; Lee J; Salim A; Brown C; Demetriades D; Rhee P
J Trauma; 2008 Dec; 65(6):1222-6. PubMed ID: 19077605
[TBL] [Abstract][Full Text] [Related]
14. Advances in resuscitation in the setting of vascular injury.
Fox CJ; Bowman JN
Perspect Vasc Surg Endovasc Ther; 2011 Jun; 23(2):112-6. PubMed ID: 21502108
[TBL] [Abstract][Full Text] [Related]
15. Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate.
Schöchl H; Forster L; Woidke R; Solomon C; Voelckel W
Anaesthesia; 2010 Feb; 65(2):199-203. PubMed ID: 19995349
[TBL] [Abstract][Full Text] [Related]
16. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
Bishop CV; Renwick WE; Hogan C; Haeusler M; Tuckfield A; Tatoulis J
Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
[TBL] [Abstract][Full Text] [Related]
17. Haemostasis management of massive bleeding.
Pötzsch B; Ivaskevicius V
Hamostaseologie; 2011 Feb; 31(1):15-20. PubMed ID: 21311819
[TBL] [Abstract][Full Text] [Related]
18. Trauma Associated Severe Hemorrhage (TASH)-Score: probability of mass transfusion as surrogate for life threatening hemorrhage after multiple trauma.
Yücel N; Lefering R; Maegele M; Vorweg M; Tjardes T; Ruchholtz S; Neugebauer EA; Wappler F; Bouillon B; Rixen D;
J Trauma; 2006 Jun; 60(6):1228-36; discussion 1236-7. PubMed ID: 16766965
[TBL] [Abstract][Full Text] [Related]
19. The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion.
Nienaber U; Innerhofer P; Westermann I; Schöchl H; Attal R; Breitkopf R; Maegele M
Injury; 2011 Jul; 42(7):697-701. PubMed ID: 21392760
[TBL] [Abstract][Full Text] [Related]
20. Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications.
Spinella PC
Crit Care Med; 2008 Jul; 36(7 Suppl):S340-5. PubMed ID: 18594261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
